Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
… serious complication of tuberculous meningitis. Treatment with dexamethasone can reduce complication rates by reducing spinal inflammation. …
…ICT clearance), rituximab (anti-CD20 for B-cell depletion), and infliximab (anti-TNF-a for T-cell and potential myeloid suppression). We h…
…6 patients were on antihistamines or montelukast and 5 received dupilumab. PD-L1 expression was available for 17 patients with a median e…
…oidosis. He was treated with intravenous methylprednisolone and infliximab, with neurological improvement.Conclusion This case highlights …
…o-Behçet’s disease. Based on this, management with steroids and infliximab was initiated.Behçet’s disease is an inflammatory multisystem v…
…ted with systemic immunosuppression, including a combination of methotrexate (n=6), adalimumab (n=5), mycophenolate (n=2), oral corticostero…
…ience supporting its long-term use. Among biological therapies, infliximab and rituximab have taken a leading role in the management of re…
…costeroids, second-line antituberculous therapy, infliximab and thalidomide. Her visual deficits initially improved but subsequently deteri…
…ombined with azathioprine (50 mg/day). He then self-switched to mesalazine (4 g/day). He returned to our hospital with severe bloody diarr…
…uding adalimumab, infliximab and vedolizumab, prior to starting Ustekinumab. 12/21 patients stopped treatment because of poor response. 4/1…
…dalimumab,50% Vedolimumab,66%(n=4) had Ustekinumab,66%(n=4) had Azathioprine. All patients received UPA as monotherapy.UPA induction was adm…
…seton insertion. The patient completed a 3-month course of oral Metronidazole.Repeat EUA 6-months following the first confirmed persistence o…